These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6820124)

  • 21. Adult cystic fibrosis patients with and without infective exacerbations and their factor XII levels.
    Davidson SJ; Paramothayan S; Hodson ME
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):400-2. PubMed ID: 19525847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin III loss in patients with nephrotic syndrome or receiving continuous ambulatory peritoneal dialysis. Evidence of inactive antithrombin III in urine of patients with nephrotic syndrome.
    De Stefano V; Triolo L; De Martini D; Ferrelli R; Mori R; Leone G
    J Lab Clin Med; 1987 May; 109(5):550-5. PubMed ID: 3572202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome.
    Kinoshita H; Fujimoto S; Fukae H; Yokota N; Hisanaga S; Nakazato M; Eto T
    Nephron; 1999 Feb; 81(2):160-4. PubMed ID: 9933751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses.
    Prinsen BHCMT; Velden MGMS; Kaysen GA; Straver HWHC; Rijn HJMV; Stellaard F; Berger R; Rabelink TJ
    J Am Soc Nephrol; 2001 May; 12(5):1017-1025. PubMed ID: 11316861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S; Yamamoto Y; Kida O; Kato J; Fujimoto S; Tanaka K
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome.
    Ozata M; Oktenli C; Gulec M; Ozgurtas T; Bulucu F; Caglar K; Bingol N; Vural A; Ozdemir IC
    J Clin Endocrinol Metab; 2002 Feb; 87(2):853-8. PubMed ID: 11836332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin.
    Magistroni R; Ligabue G; Lupo V; Furci L; Leonelli M; Manganelli L; Masellis M; Gatti V; Cavazzini F; Tizzanini W; Albertazzi A
    Nephrol Dial Transplant; 2009 May; 24(5):1672-81. PubMed ID: 19211645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.
    Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M
    J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
    Hu P; Lu L; Hu B; Du PF
    Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary iron loss in the nephrotic syndrome--an unusual cause of iron deficiency with a note on urinary copper losses.
    Brown EA; Sampson B; Muller BR; Curtis JR
    Postgrad Med J; 1984 Feb; 60(700):125-8. PubMed ID: 6709543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electroimmunoassay of factor XII antigen increased sensitivity by silver staining of immunoprecipitate--factor XII antigen in cases from 9 Japanese families with congenital factor XII deficiency].
    Takamiya O; Funahashi S; Kinoshita S; Yoshioka K; Sakata M; Yoshikawa I; Yoshioka A
    Rinsho Byori; 1987 Nov; 35(11):1282-6. PubMed ID: 2451044
    [No Abstract]   [Full Text] [Related]  

  • 35. Decreased factor XII activity in a child with nephrotic syndrome and thromboembolic complications.
    Negrier C; Delmas MC; Ranchin B; Cochat P; Dechavanne M
    Thromb Haemost; 1991 Oct; 66(4):512-3. PubMed ID: 1796406
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonrenal complications of the nephrotic syndrome.
    Kaysen GA
    Annu Rev Med; 1994; 45():201-10. PubMed ID: 8198377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor-XII congenital deficiency. A new family study.
    Lucia JF; Ercoreca L; Torres M; Giralt M; Raichs A
    Thromb Haemost; 1979 Oct; 42(3):1009-17. PubMed ID: 505391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concentration of acid-stable inhibitors--metabolites of plasma inter-alpha trypsin inhibitor--in the urine of healthy people and in patients with nephrotic syndrome].
    Ogloblina OG; Poliantseva LR; Paskhina TS
    Vopr Med Khim; 1984; 30(2):104-8. PubMed ID: 6204451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.